Snowflake (SNOW) director sells 437,076 shares after option exercise
Rhea-AI Filing Summary
Snowflake Inc. director Frank Slootman reported a combination of option exercise and open-market sales of the company’s common stock. On May 29, 2026, he exercised 437,076 stock options at an exercise price of $8.88 per share and acquired the same number of common shares. He then sold 437,076 shares in multiple open-market transactions at weighted-average prices reported around the mid‑$250s per share, all carried out under a Rule 10b5-1 trading plan adopted on September 19, 2025. Following these transactions, he held 352,257 Snowflake common shares directly, along with additional shares held indirectly through several family trusts, where individual trust positions ranged from 16,300 to 78,893 shares as of the reported date. After the exercise, a related stock option position showed 5,499,579 options remaining outstanding.
Positive
- None.
Negative
- None.
Insights
Slootman executed an exercise-and-sell under a 10b5-1 plan, leaving a large remaining equity stake.
The filing shows Frank Slootman exercising 437,076 stock options at an exercise price of $8.88 per share and selling the resulting shares in open-market transactions around the mid‑$250 range. This is a classic executive compensation pattern: converting options into shares, then into cash.
Importantly, these trades were effected under a Rule 10b5-1 trading plan adopted on September 19, 2025, indicating they were pre-scheduled rather than timed opportunistically. After the transactions, he still held 352,257 common shares directly and maintained a sizable option position of 5,499,579 remaining stock options, suggesting continued significant exposure to Snowflake’s equity.
The combination of planned sales and substantial remaining holdings points to routine liquidity management rather than a clear directional signal about Snowflake’s prospects. Future company filings may provide additional context on how his equity position evolves over time and how quickly remaining options are exercised ahead of their May 28, 2029 expiration.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 437,076 | $0.00 | -- |
| Exercise | Common Stock | 437,076 | $8.88 | $3.88M |
| Sale | Common Stock | 122,865 | $250.441 | $30.77M |
| Sale | Common Stock | 97,386 | $251.605 | $24.50M |
| Sale | Common Stock | 38,635 | $252.405 | $9.75M |
| Sale | Common Stock | 75,226 | $253.36 | $19.06M |
| Sale | Common Stock | 64,328 | $254.436 | $16.37M |
| Sale | Common Stock | 34,571 | $255.723 | $8.84M |
| Sale | Common Stock | 4,065 | $256.022 | $1.04M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. Includes shares to be issued in connection with the vesting of one or more restricted stock units. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $250.000 to $250.990, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $251.000 to $251.995, inclusive. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $252.000 to $252.980, inclusive. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $253.000 to $253.990, inclusive. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $254.000 to $254.990, inclusive. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $255.000 to $255.990, inclusive. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $256.000 to $256.150, inclusive. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee. The stock option is fully vested.